Skip to main content
Cell Death Discovery logoLink to Cell Death Discovery
. 2021 Jun 15;7:146. doi: 10.1038/s41420-020-00388-7

Correction: BCL-XL is an actionable target for treatment of malignant pleural mesothelioma

Surein Arulananda 1,2,3, Megan O’Brien 1, Marco Evangelista 1, Tiffany J Harris 1, Nikita S Steinohrt 1, Laura J Jenkins 1,2, Marzena Walkiewicz 1, Robert J J O’Donoghue 1,8, Ashleigh R Poh 1,2, Bibhusal Thapa 1, David S Williams 1,2,4,5, Trishe Leong 3,4,5, John M Mariadason 1,2, Xia Li 6, Jonathan Cebon 1,2,3, Erinna F Lee 1,2,7,, Thomas John 1,2,3,9,, W Douglas Fairlie 1,2,7,
PMCID: PMC8206255  PMID: 34131107

Correction to: Cell Death Discovery

10.1038/s41420-020-00348-1 published online 31 October 2020

The original version of this article unfortunately contained an error in the name of one of the authors (WD Fairlie). This has been corrected in the PDF and HTML versions. The original article has been corrected.

Footnotes

Edited by Inna Lavrik

Contributor Information

Erinna F. Lee, Email: Erinna.Lee@latrobe.edu.au

Thomas John, Email: tom.john@petermac.org.

W. Douglas Fairlie, Email: doug.fairlie@onjcri.org.au.


Articles from Cell Death Discovery are provided here courtesy of Nature Publishing Group

RESOURCES